Smith, Amanda J.

Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells

Vidana Gamage, H. E., Albright, S. T., Smith, A. J., Farmer, R., Shahoei, S. H., Wang, Y., Fink, E. C., Jacquin, E., Weisser, E., Bautista, R. O., et al. (2024) · Cancer Letters

Cancer Immunotherapy and BiomarkersImmune cells in cancer

Cited by 13

Undisclosed HIV infection among MSM in a behavioral surveillance study.

Hoots, B. E., Wejnert, C., Martin, A., Haaland, R., Masciotra, S., Sionean, C., Smith, A., Switzer, W. M., & Paz-Bailey, G. (2019) · AIDS

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 10

NR0B2 re-educates myeloid immune cells to reduce regulatory T cell expansion and progression of breast and other solid tumors

Vidana Gamage, H. E., Shahoei, S. H., Wang, Y., Jacquin, E., Weisser, E., Bautista, R. O., Henn, M. A., Schane, C. P., Nelczyk, A. T., Ma, L., et al. (2024) · Cancer Letters

Immune cells in cancerCancer Immunotherapy and Biomarkers

Cited by 9